INNOVATIVE TECHNOLOGY TO MEET YOUR NEEDS
Eurofins is fully equipped to perform organism identification, characterization, and antimicrobial susceptibility testing using conventional or automated methods. Depending on the specifics in the Study Protocol, our Microbiology Laboratories commence bacteriology testing from both isolates and clinical samples (raw specimens) provided by the investigational sites.
Building on classical microbiology methodologies, Eurofins sets the standard in molecular infectious disease testing through advanced, high-quality assay development and performance. Our extensive suite of molecular virology, mycology and bacterial assays is leading through innovation and rapid turnaround times and includes Pathogen Detection, Antiviral Resistance Assessment, Pathogen Characterization and Pathogen Load Monitoring.
PATHOLOGY AND ONCOLOGY SERVICES
The deployment of Pathology testing has become increasingly important in Oncology Trials. Pathology testing is facing similar challenges as Central Laboratory testing; large sample numbers distributed over many locations, a need for expert global logistics support to maintain specimen integrity, quick turnaround time of results and the necessity for globally combinable data.
With a keen eye on the specifics of a clinical trial, Eurofins offers anatomic, clinical and molecular pathology services to assess traditional clinical-pathological factors as well as the molecular biological features of a given tumor to support Safety, Vaccine and Oncology trials.
GENOMICS IN CLINICAL TRIALS
By using RNA and DNA analysis methodologies, we are able to help our customers understand why patients with identical conditions react to an equal drug treatment in different ways. Some patients may be designated as non-responders or may even experience severe adverse effects that can be attributed to genetic variation. Genetic information can also be of predictive value to determine whether clinical trial subjects should be included or excluded based on protocol requirements
Eurofins has extensive experience in applying the different genetic analysis methods and techniques which are crucial for the entire drug development process. Our Genomics Services portfolio includes DNA/RNA extraction, GLP-compliant genotyping and sequencing, SNP, mutation and genetic biomarker analysis, expression analysis and tumor profiling via Next Generation Sequencing.
Eurofins Central Laboratory is your window to utilizing the Eurofins powerhouse for bioanalytical services. Our mission is to extend our clients’ capabilities by combining scientific knowledge, capacity, regulatory expertise and flexibility to provide the trusted, relevant information required for the drug approval process.
Testing services include preclinical ADME and Toxicokinetics, Anti-Drug Antibodies (ADA), and clinical PK analysis of small and large molecules (biopharmaceuticals), immunogenicity testing and biosimilars testing.